Loading
Latest filing published 10 Sept 2024 for Cardio Diagnostics Holdings, Inc., €1,912.
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Philibert is a declared insider of Cardio Diagnostics Holdings, Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 24 August 2023 to 6 September 2024.
No open-market sale appears; the market trades are 5 purchases worth €28k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2024, the count stands at 2 purchases and no sales.
In size, the median ticket on the buying side is €6,875. 2 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +171.3%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 10 September 2024, the filings show an open-market purchase worth €1,912 in Cardio Diagnostics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 8 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations